(Q28371742)

English

Cladribine with or without prednisone in the treatment of previously treated and untreated B-cell chronic lymphocytic leukaemia - updated results of the multicentre study of 378 patients

scientific article

In more languages

Statements

scholarly article

0 references

Cladribine with or without prednisone in the treatment of previously treated and untreated B-cell chronic lymphocytic leukaemia - updated results of the multicentre study of 378 patients (English)

0 references

multicenter clinical trial

0 references

0 references

0 references

1 reference

based on heuristic

inferred from title

chronic lymphocytic leukemia

1 reference

based on heuristic

inferred from title

B-cell chronic lymphocytic leukemia

1 reference

based on heuristic

inferred from title

Anna Dmoszyńska

6

object named as

A Dmoszyńska

0 references

Jerzy Hołowiecki

20

object named as

J Holowiecki

0 references

Aleksander Skotnicki

8

object named as

A B Skotnicki

0 references

Jadwiga Dwilewicz-Trojaczek

10

object named as

J Dwilewicz-Trojaczek

0 references

1

object named as

T Robak

0 references

Kazimierz Kuliczkowski

14

object named as

K Kuliczkowski

0 references

author name string

J Z Bloński

2

0 references

M Kasznicki

3

0 references

L Konopka

4

0 references

B Ceglarek

5

0 references

M Soroka-Wojtaszko

7

0 references

W Nowak

9

0 references

A Tomaszewska

11

0 references

A Hellmann

12

0 references

K Lewandowski

13

0 references

S Potoczek

15

0 references

B Zdziarska

16

0 references

J Hansz

17

0 references

R Kroll

18

0 references

M Komarnicki

19

0 references

P Grieb

21

0 references

language of work or name

0 references

publication date

February 2000

0 references

British Journal of Haematology

0 references

108

0 references

357-68

0 references

2

0 references

Listeriosis in patients with chronic lymphocytic leukemia who were treated with fludarabine and prednisone

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2000.01850.X

21 January 2018

Fewer infections, but maintained antitumor activity with lower-dose versus standard-dose cladribine in pretreated low-grade non-Hodgkin's lymphoma

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2000.01850.X

21 January 2018

Treatment of chronic lymphocytic leukaemia. French Co-operative Group on CLL.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2000.01850.X

21 January 2018

Long-term clinical outcome of B-cell chronic lymphocytic leukaemia patients in clinical remission phase evaluated at phenotypic level.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2000.01850.X

21 January 2018

Prognostic factors in chronic lymphocytic leukaemia: the importance of age, sex and response to treatment in survival. A report from the MRC CLL 1 trial. MRC Working Party on Leukaemia in Adults

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2000.01850.X

21 January 2018

Key issues in the treatment of chronic lymphocytic leukaemia (CLL)

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2000.01850.X

21 January 2018

Guidelines for clinical protocols for chronic lymphocytic leukemia: recommendations of the National Cancer Institute-sponsored working group

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2000.01850.X

21 January 2018

High dose chlorambucil versus Binet's modified cyclophosphamide, doxorubicin, vincristine, and prednisone regimen in the treatment of patients with advanced B-cell chronic lymphocytic leukemia. Results of an international multicenter randomized tria

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2000.01850.X

21 January 2018

High complete remission rate from 2-chloro-2'-deoxyadenosine in previously treated patients with B-cell chronic lymphocytic leukemia: response predicted by rapid decrease of blood lymphocyte count

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2000.01850.X

21 January 2018

Response to 2-chlorodeoxyadenosine in patients with B-cell chronic lymphocytic leukemia resistant to fludarabine

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2000.01850.X

21 January 2018

Nonparametric Estimation from Incomplete Observations

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2000.01850.X

21 January 2018

Chronic lymphocytic leukaemia treatment

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2000.01850.X

21 January 2018

Fludarabine and granulocyte colony-stimulating factor (G-CSF) in patients with chronic lymphocytic leukemia

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2000.01850.X

21 January 2018

Lack of effect of 2-chlorodeoxyadenosine therapy in patients with chronic lymphocytic leukemia refractory to fludarabine therapy

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2000.01850.X

21 January 2018

Toxicity and response criteria of the Eastern Cooperative Oncology Group

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2000.01850.X

21 January 2018

2-Chlorodeoxyadenosine activity in patients with untreated chronic lymphocytic leukemia

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2000.01850.X

21 January 2018

Treatment of refractory chronic lymphocytic leukemia with fludarabine phosphate via the group C protocol mechanism of the National Cancer Institute: five-year follow-up report

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2000.01850.X

21 January 2018

Identifiers

10.1046/J.1365-2141.2000.01850.X

0 references

0 references

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q28371742&oldid=2124614874"